The New York Racing Association Oct. 17 expressed its full support of the New York State Gaming Commission's proposed rules on threshold limits for therapeutic medications on race day.
The Racing Medication and Testing Consortium plans to recommend a model policy on anabolic steroids later this year and also has approved a plan to establish model policies for withdrawal times for therapeutic drugs used in racehorses.
As the National Thoroughbred Racing Association Racing Integrity and Drug Testing Task Force prepared to release the results of round two of its super-testing program, the University of Florida appropriately kicked off its first Equine Medical Symposium March 14 with discussion on some therapeutic medications.
Therapeutic medications will be the focus of the next round of "Super-Testing," the results of which should be available the first week of December during the University of Arizona Symposium on Racing. More than 500 blind samples remain to be tested for Class 4 medications.
Most Popular Stories
- American Pharoah Takes Easy Gallop at Spa
- Belmont Winner Palace Malice Retired
- NBC Schedules Two-Hour Travers Broadcast
- OBS Yearling Sale Stays Steady on Final Day
- Travers Stakes: High Anxiety
- Violette Undecided on Travers for Upstart
- Illinois Vote Could Impact Thoroughbred Dates
- Making a Case for Transparency
- Stellar Wind Tops Torrey Pines Field
- Keeneland Plans for Sale Activity During BC